Engaging Cell Death Pathways for the Treatment of Rhabdomyosarcoma.

Abstract

Rhabdomyosarcoma (RMS), a malignant neoplasm of presumed mesenchymal origin, is the most common soft tissue cancer of childhood. Despite aggressive treatment, resistance to current therapies remains a challenge. The success of most cytotoxic chemotherapies requires intact programmed cell death (apoptosis) pathways. Defects in the cellular apoptotic program… (More)

Topics

  • Presentations referencing similar topics